Add to ORKGThe invention relates generally to novel N-thiolated β-lactams. More specially, the invention relates to the use of these novel antibacterial agents in the treatment or inhibition of methicillin-resistant Staphylococcus aureaus
Resistance to β-lactam antibiotics can be mediated by metallo-β-lactamase enzymes (MBLs). An MBL inh...
The resistance of methicillin-resistant Staphylococcus aureus (MRSA) to all -lactam classes limits t...
This invention describes the discovery and synthesis of N-thiolated 2-oxazolidinones as a new class ...
The invention relates generally to novel N-thiolated β-lactams. More specially, the invention relate...
The invention relates to heterosubstituted N-thiolated beta-lactams, compositions comprising these c...
N-Methylthio beta-lactams represent a promising new family of antibacterial agents whose in vitro ac...
N-Thiolated beta-lactams are a new class of anti-MRSA and anti-Bacillus agents that have recently be...
The Turos laboratory has been working with N-thiolated β-lactams for years trying to understand the ...
Drug resistance has become a global problem in virtually all areas of infectious diseases. The urgen...
N-Thiolated β-lactams (1) represent a promising new group of compounds with potent inhibition effect...
Work in the Turos group over the past five years has focused on the development of N-alkylthio beta-...
This invention describes the discovery and synthesis of N-thiolated 2-oxazolidinones as a new class ...
The β-lactams have a central place in the antibacterial armamentarium, but the increasing resistance...
This invention describes the discovery and synthesis of N-thiolated 2-oxazolidinones as ...
Pathogens, expressing metallo-β-lactamases (MBLs), become resistant against most β-lactam antibiotic...
Resistance to β-lactam antibiotics can be mediated by metallo-β-lactamase enzymes (MBLs). An MBL inh...
The resistance of methicillin-resistant Staphylococcus aureus (MRSA) to all -lactam classes limits t...
This invention describes the discovery and synthesis of N-thiolated 2-oxazolidinones as a new class ...
The invention relates generally to novel N-thiolated β-lactams. More specially, the invention relate...
The invention relates to heterosubstituted N-thiolated beta-lactams, compositions comprising these c...
N-Methylthio beta-lactams represent a promising new family of antibacterial agents whose in vitro ac...
N-Thiolated beta-lactams are a new class of anti-MRSA and anti-Bacillus agents that have recently be...
The Turos laboratory has been working with N-thiolated β-lactams for years trying to understand the ...
Drug resistance has become a global problem in virtually all areas of infectious diseases. The urgen...
N-Thiolated β-lactams (1) represent a promising new group of compounds with potent inhibition effect...
Work in the Turos group over the past five years has focused on the development of N-alkylthio beta-...
This invention describes the discovery and synthesis of N-thiolated 2-oxazolidinones as a new class ...
The β-lactams have a central place in the antibacterial armamentarium, but the increasing resistance...
This invention describes the discovery and synthesis of N-thiolated 2-oxazolidinones as ...
Pathogens, expressing metallo-β-lactamases (MBLs), become resistant against most β-lactam antibiotic...
Resistance to β-lactam antibiotics can be mediated by metallo-β-lactamase enzymes (MBLs). An MBL inh...
The resistance of methicillin-resistant Staphylococcus aureus (MRSA) to all -lactam classes limits t...
This invention describes the discovery and synthesis of N-thiolated 2-oxazolidinones as a new class ...